BTIG Research initiated coverage on Cartesian Therapeutics with a new price target

12/19/24 8:25:53 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

BTIG Research initiated coverage of Cartesian Therapeutics with a rating of Buy and set a new price target of $42.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RNAC

Date	Price Target	Rating	Analyst
12/19/2024	$42.00	Buy	BTIG Research
8/6/2024		Buy	TD Cowen
7/2/2024		Outperform → Perform	Oppenheimer
6/4/2024	$50.00	Outperform	Oppenheimer
5/24/2024	$40.00	Buy	Mizuho
4/23/2024	$2.00 → $54.00	Buy	H.C. Wainwright
4/23/2024	$39.00	Outperform	Leerink Partners